Treatment of type 1 diabetes in children and adolescents using modern insulin pumps
Tài liệu tham khảo
DCCT Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401
DCCT Group, 1994, Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial, J Pediatr, 125, 177, 10.1016/S0022-3476(94)70190-3
Prince, 2007, Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC), Diabetologia, 50, 2280, 10.1007/s00125-007-0797-7
Mortensen, 1998, Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes, Diabetic Med, 15, 752, 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W
Holder, 2007, Trends in der Insulinpumpentherapie bei Kindern, Jugendlichen und jungen Erwachsenen mit Typ-1-Diabetes von 1995-2006: Daten der DPV-Initiative, Diabetologie, 2, 169, 10.1055/s-2007-960666
Boland, 1999, Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes, Diabetes Care, 22, 1779, 10.2337/diacare.22.11.1779
Danne, 2008, Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries, Diabetologia, 51, 1594, 10.1007/s00125-008-1072-2
Phillip, 2007, Diabetes Care, 30, 1653, 10.2337/dc07-9922
Berghaeuser, 2008, German working group for insulin pump treatment in paediatric patients. Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria, Pediatr Diabetes, 9, 590, 10.1111/j.1399-5448.2008.00416.x
Danne, 2006, Current practice of insulin pump therapy in children and adolescents - the Hannover recipe, Pediatr Diabetes, 7, 25, 10.1111/j.1399-543X.2006.00166.x
Ahern, 2002, Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbAlc levels across all age groups, Pediatr Diabetes, 3, 10, 10.1034/j.1399-5448.2002.30103.x
Hanas, 2002, Selection for and initiation of continuous subcutaneous insulin infusion, Horm Res, 57, 101
Holterhus, 2007, Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy, Diabetes Care, 30, 568, 10.2337/dc06-2105
Danne, 2005, A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries, Pediatr Diabetes, 6, 193, 10.1111/j.1399-543X.2005.00131.x
Klinkert, 2008, Age-specific characteristics of the basal insulin-rate for pediatrie patients on CSII, Exp Clin Endocrinol Diabetes, 116, 118, 10.1055/s-2007-990296
O'Connell, 2008, Optimizing postprandial glycemia in pediatrie patients with typel diabetes using insulin pump therapy, Diabetes Care, 31, 1491, 10.2337/dc08-0306
Chase, 2002, Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes, Diabet Med, 19, 317, 10.1046/j.1464-5491.2002.00685.x
Pankowska, 2009, Application of novel dual wave meal bolus and its impact on glycated hemoglobin Ale level in children with type 1 diabetes, Pediatr Diabetes, 10, 298, 10.1111/j.1399-5448.2008.00471.x
Tubiana-Rufi, 2004, Special management of insulin lispro in continuous subcutaneous insulin infusion in young diabetic children: a randomized cross-over study, Horm Res, 62, 265
Jorgensen, 2005, Dilution of Novolog (insulin aspart 100 U/ml) with NPH medium for small dose use in continuous subcutaneous insulin infusion does not affect in-vitro stability, Diabetes, 54, A102
Bharucha, 2005, Neonatal diabetes mellitus: insulin pump as an alternative management strategy, J Paediatr Child Health, 41, 522, 10.1111/j.1440-1754.2005.00696.x
Danne, 2001, Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group, Diabetes Care, 24, 1342, 10.2337/diacare.24.8.1342
Jakisch, 2008, Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years, Diabet Med, 25, 80, 10.1111/j.1464-5491.2007.02311.x
Kordonouri, 2006, Age-specific advantages of continuous subcutaneous insulin infusion (CSII) as compared with multiple daily injections (MDI) in pediatrie patients: one year follow-up comparison by matched-pair analysis, Diabetes Care, 29, 133, 10.2337/diacare.29.01.06.dc05-1740
Nimri, 2006, Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study, Pediatrics, 117, 2126, 10.1542/peds.2005-2621
Pickup, 2008, Severe hypoglycaemia and glycaemic control in Typel diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion, Diabet Medicine, 25, 765, 10.1111/j.1464-5491.2008.02486.x
Jeitler, 2008, Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis, Diabetologia, 51, 941, 10.1007/s00125-008-0974-3
Pankowska, 2009, Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials, Pediatr Diabetes, 10, 52, 10.1111/j.1399-5448.2008.00440.x
Misso, 2010, Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus, Cochrane Database Syst Rev, 1
Weissberg-Benchell, 2003, Insulin pump therapy: a meta-analysis, Diabetes Care, 26, 1079, 10.2337/diacare.26.4.1079
Pickup, 2002, Continuous subcutaneous insulin infusion at 25years: Evidence base for the expanding use of insulin pump therapy in typel diabetes, Diabetes Care, 25, 593, 10.2337/diacare.25.3.593
Linkeschova, 2002, Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years, Diabet Med, 19, 746, 10.1046/j.1464-5491.2002.00713.x
Knight, 2009, Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with typel diabetes mellitus: a pilot study, Diabetologia, 52, 193, 10.1007/s00125-008-1197-3
Halvorson, 2007, A Pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump, J Pediatr, 150, 103, 10.1016/j.jpeds.2006.08.069
Hirsch, 2008, Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study, Diabetes Technol Ther, 10, 377, 10.1089/dia.2008.0068
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, 2008, Continuous glucose monitoring and intensive treatment of type 1 diabetes, N Engl J Med, 359, 1464, 10.1056/NEJMoa0805017
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, 2009, Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes, Diabetes Care, 32, 1947, 10.2337/dc09-0889
Kordonouri, 2010, Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes - results of the pediatrie ONSET study after 12 months of treatment, Diabetologia, 53, 2487, 10.1007/s00125-010-1878-6